Company creation case studies

With a wealth of financial services experience and world-leading Natural Language Processing (NLP) expertise, University of Edinburgh spinout Aveni is creating cutting-edge AI solutions that are built specifically for the financial services industry.

Pioneers in the AI healthcare space, University of Edinburgh spinout Blackford Analysis is tapping into the potential of AI to enhance clinical practices and usher in a new era of patient care.

Billions of people around the world are bilingual, yet bilingualism remains largely misunderstood and much of the existing research is inaccessible.

Spinout company Concinnity Genetics is transforming the safety of gene therapies by designing novel control mechanisms using its cutting-edge AI platform and synthetic biology expertise.

Earth Blox is a cloud-based software-as-a-service provider that empowers anyone, anywhere to create their own Earth observation and satellite data solutions.

University of Edinburgh spinout Exergy3 has developed modular thermal energy storage systems that convert green energy into heat and store it at ultra-high temperatures, offering decarbonisation services with a multitude of applications.

Macomics is a spinout company from the Centre for Reproductive Health at the University of Edinburgh, developing novel therapeutics to modulate the activity of macrophages, increasing the body’s immune defence against tumours in cancer sufferers.

Dr Patras and his team were able to turn their novel technology into a commercial proposition through support from Edinburgh Innovations Enterprise team.

After a first degree in physics and a PhD in optical techniques, Dr Alex McVey joined Prof Teuta Pilizota’s lab, where they quickly discovered the pain of manually culturing bacteria.

With support from Edinburgh Innovations, Pheno Therapeutics, a spinout from the University of Edinburgh has combined world-class clinical and drug discovery expertise, and is uniquely positioned to provide novel treatments that could halt the progression and alleviate the debilitating symptoms of multiple sclerosis (MS).

Prothea Technologies is a spinout company from the Universities of Edinburgh and Bath developing technology that promises to ‘see and treat’ diseased lung tissue in a single hospital visit.

When specialist healthcare investment company Syncona Ltd discovered the ground-breaking cell therapy research being conducted by scientists at the University of Edinburgh it sparked a collaboration that went on to fuel the launch of pioneering biotechnology spinout Resolution Therapeutics.

A collaborative research project between world-leading researchers in healthcare and computer sciences at the University of Edinburgh has led to the launch of spinout company SpeakUnique, which provides a state-of-the-art synthetic voice personalisation service for communication aid users.